trans-cinnamaldehyde, min 98.5%, for synthesis, 250 ml, glass packaging

1-(2-Propen-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

tert-Butyl(2-iodoethoxy)dimethylsilane, 95.0%, 25g

3-(2,2-Dimethyl-[1,3]dioxolan-4-ylmethoxy)-propylamine, 95+%, 5g

3-Chloro-2-naphthoic acid, 100mg

5-[(4-Benzyloxy)benzyl]-2,4-diaminopyrimidine, 95%, 250mg

1-(6-chloropyridin-3-yl)-4,4,4-trifluoro-3-hydroxybut-2-en-1-one, 95%, 1g

(3-Bromo-6-ethoxy-2-fluorophenyl)boronic acid, 97.0%, 10g

D-PIPERCOLIC ACID HYDROCHLORIDE, 97.0%, 1g

2,6-Difluorobenzenesulfonyl Chloride>98.0%(GC)(T)5g

3-chloro-5H,6H,7H,8H-imidazo[1,2-a]pyrazine, 95.0%, 500mg

2,5-Bis(Trifluoromethyl)chlorobenzene, 95.0%, 5g

6-IODO-8-PHENYLIMIDAZO[1,2-A]PYRAZINE, 95%, 250mg